Global Undenatured Type II Collagen Market Strategic Research Report

Scope of the Report

The global Undenatured Type II Collagen market size is predicted to grow from US$ 184 million in 2025 to US$ 275 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Undenatured Type II Collagen is a type of collagen extracted from animal cartilage using a patented low-temperature extraction technology. Its triple helix structure and biological activity are completely preserved. It is the type II collagen in nature that is most similar to the structure of human and animal articular cartilage and has high purity and biological activity.

The main source of undenatured type II collagen is cartilage resources from slaughterhouse by-products of poultry (most commonly chicken sternum/breast cartilage). The key to the supply side lies in "low-temperature/mild condition extraction and purification" to maintain the triple-helical structure and active epitopes of type II collagen as much as possible.

In 2025, global sales are projected to be approximately 852.5 tons, with an average market price of around $221 per kilogram. The industry's gross profit margin is expected to be in the range of 20%–40%.

<p class="tw-data-text tw-text-large tw-ta" data-placeholder="翻译" id="tw-target-text" role="text" tabindex="-1" data-ved="2ahUKEwjhzKLyvcaRAxVrEDQIHWQcFTUQ3ewLegQIIBAW" dir="ltr" aria-label="译文：The deepening global aging trend and the year-on-year increase in the incidence of osteoarthritis provide a huge foundation of unmet demand for this industry. Furthermore, its inherent advantages compared to traditional joint health ingredients (such as glucosamine and chondroitin) in terms of mechanism of action, effective dosage, and clinical data have gained increasing recognition from both brands and consumers.

Despite the promising prospects, high extraction costs and technological barriers remain major obstacles to widespread adoption. At the same time, industry irregularities cannot be ignored; currently, there are many instances of inexpensive hydrolyzed collagen being passed off as non-denatured active protein on the market.">The deepening global aging trend and the year-on-year increase in the incidence of osteoarthritis provide a huge foundation of unmet demand for this industry. Furthermore, its inherent advantages compared to traditional joint health ingredients (such as glucosamine and chondroitin) in terms of mechanism of action, effective dosage, and clinical data have gained increasing recognition from both brands and consumers.Despite the promising prospects, high extraction costs and technological barriers remain major obstacles to widespread adoption. At the same time, industry irregularities cannot be ignored; currently, there are many instances of inexpensive hydrolyzed collagen being passed off as non-denatured active protein on the market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Undenatured Type II Collagen market?

What factors are driving Undenatured Type II Collagen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Undenatured Type II Collagen market opportunities vary by end market size?

How does Undenatured Type II Collagen break out by Type, by Application?

This report presents a comprehensive overview of the global Undenatured Type II Collagen market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Chicken Breast Cartilage
• Other

Segment by Collagen Content

• ≥90%
• <90%

Segment by Form

• Powder
• Tablets

Segment by Application

• Food
• Medicine

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Undenatured Type II Collagen market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Food, Medicine evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact